Zymergen is a technology company that integrates automation, machine learning, and genomics to rapidly accelerate the pace of scientific advancement.
Zymergen develops molecules for agriculture, chemicals, materials, pharmaceuticals, electronics, personal care, and more applications. The company researches, develops, and manufactures microbes for Fortune 500 companies.
Zymergen was founded in 2013 and is based in Emeryville, CA with an additional office in Seattle, Washington.
Zymergen leverage machine learning to make discoveries far beyond the bounds of human intuition. In doing so, it delivers economic value, material diversity and performance capabilities not previously possible.
Zymergen offers new product development, such as engineering any molecules from any microbes that improves the power of biology to develop novel products.
Zymergen's platform integrates automation, machine learning, and genomics to navigate the genomic search space. It uses a technology platform to optimize strains in that improves economics; improves the existing production strains within existing manufacturing processes; and improves the correlation between the lab and commercial manufacturing.
Zymergen is backed by top-tier investors including Goldman Sachs, True Ventures, Two Sigma Ventures, Data Collective DCVC, and SoftBank Vision Fund among others. The company has acquired Radiant Genomics in Jan 8, 2018.